A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

Hyperglycemia is a marker for poor clinical outcome and mortality in hospitalized patients. In the critical care setting, insulin administered intravenously or subcutaneously is effective.

Objective: Despite the demonstrated benefits of glycemic control, patient acceptance of basal/bolus insulin therapy for type 1 diabetes has been slow. We investigated whether a basal/bolus insulin ...

The FDA has approved the first smartphone application capable of initiating insulin delivery for insulin pump wearers, according to a company press release. Tandem Diabetes Care has received clearance ...

For patients with type 2 diabetes who are taking multiple daily insulin injections, switching to combination treatment with basal insulin plus an agent from one of two newer glucose-lowering drug ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN FRANCISCO — Adults with type 2 diabetes inadequately ...

Companion Medical announced that it has received clearance from the Food and Drug Administration (FDA) for a new bolus calculator for fixed dosing and meal estimation to be used with the InPen system.

A decade ago, the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE) updated treatment guidelines for hospital patients outside the intensive care ...

(HealthDay News) – A structured course teaching the benefits of automated bolus calculator (ABC) use and flexible intensive insulin therapy (FIIT) improves metabolic control and satisfaction in ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that t:slim X2 insulin pump users have delivered more ...